The concept of data as a valuable commodity is shifting from theoretical economics to a practical battleground in the technology and healthcare sectors. As artificial intelligence models increasingly rely on massive datasets to improve, the question of who owns, controls, and ultimately profits from that data has become a point of tension for industry leaders. While some executives express concern over how AI companies aggregate information from business partners, the broader discussion involves whether the individuals generating personal data—particularly in healthcare—should be compensated for their role in fueling these systems.
The Evolution of Data Ownership and AI
The current friction between data providers and AI model builders highlights a structural shift in the digital economy. According to a report by The Wall Street Journal, Palantir Technologies CEO Alex Karp has publicly criticized the methods used by major AI firms to harvest insights from their customers, stating that “Something has gone completely wrong.” This sentiment reflects a growing discomfort among established technology firms that find their proprietary data being used to train models that may eventually compete against them in specific market verticals.
This dynamic is further complicated by the rapid expansion of AI companies into specialized fields. As noted by former White House AI czar David Sacks, firms like Anthropic have moved to release targeted tools for science, security, and legal sectors, effectively bypassing the third-party companies that previously built solutions atop their core models. This strategy allows AI developers to capture the most lucrative aspects of an industry by controlling the model layer itself, leaving data-generating partners in a position of reduced leverage.
Data Generation and Healthcare Costs
In the healthcare sector, the disconnect between data generation and financial return is particularly stark. The U.S. healthcare system, which is closing in on $6 trillion in expenditures, relies on a constant stream of patient data. This information is generated through every interaction—from doctor visits, lab work, and pharmacy claims to the increasing use of personal health wearables.
Despite the immense volume of this data, the financial benefits rarely accrue to the patients who generate it. Instead, the current system is characterized by high, rising costs, with premiums and out-of-pocket expenses increasing for many Americans. A small percentage of people account for the vast majority of healthcare spending, creating a cycle where premiums rise to cover these expenses, often making premiums for the remaining people higher.
The Potential for Revaluing Health Data
Proponents of a new economic model for healthcare suggest that if AI is to reshape the industry, it must address the fundamental imbalance in data ownership. If AI companies require vast amounts of information to optimize care delivery and identify waste—estimated as much as one-third—there is a logical argument for treating that data as a resource with inherent value. Some propose that instead of patients being solely responsible for the rising costs of care, they could be compensated for the data they provide, effectively turning them into active participants in the value chain.
The challenge remains that current healthcare data is often de-identified and sold in bulk, with the value captured by intermediaries rather than the individuals involved. It is argued that current market valuations of personal health data are low because companies have become accustomed to acquiring it cheaply. A market correction, where data providers gain control over their own information, could theoretically help bring the costs of healthcare services and the value of health data closer to equilibrium.
Future Directions in Data Policy
The path forward involves a fundamental reconsideration of how digital value is realized. For individuals, the focus remains on how to ensure that the information captured by wearables and medical providers is used in their best interests, rather than merely as fuel for external commercial models.
We encourage readers to share their perspectives on whether the current model of data collection serves the public interest or if a shift toward direct compensation is necessary.
Related reading